Solara Active Pharma Sciences Ltd

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 please find enclose the transcript of the earnings conference call for the quarter ended December 31 2022 conducted after the meeting of Board of Directors held on January 25 2023 for your information and records.